By
Adrianne Appel2024-02-27T20:34:00
Environmental, social, and governance issues are increasingly material to investors, and the Securities and Exchange Commission (SEC) is checking to ensure businesses’ ESG statements are above board, according to the agency’s enforcement director.
“It is … crucial that when companies speak about the host of issues that may fall under the rubric of ESG, whether climate, social, corporate governance, or others, they do so in a way that’s not materially false or misleading,” said Gurbir Grewal on Friday in remarks delivered at the Ohio State Law Journal Symposium.
Investors care greatly about ESG matters and make investment decisions based on what companies report about meeting their ESG targets, Grewal said.
2024-10-22T16:08:00Z By Aaron Nicodemus
Fund management company WisdomTree will pay $4 million to settle allegations by the Securities and Exchange Commission that it improperly invested in fossil fuel and tobacco companies in environmental, social and governance (ESG) funds despite promising to avoid them.
2024-02-27T12:25:00Z By Kyle Brasseur
Retail giant Walmart announced the completion of an initiative to reduce emissions in its supply chain six years earlier than its intended target.
2024-02-05T12:13:00Z By Neil Hodge
Tech vendors believe ESG reporting is a ripe market for artificial intelligence to help companies sift through data and ensure compliance with both mandatory and voluntary reporting standards. Compliance officers appear less sure.
2025-11-05T18:35:00Z By Oscar Gonzalez
Approximately $9 billion of potential shadow-banking flows tied to Iranian networks in 2024, according to a new analysis from FinCEN. The report highlights how illicit funds are making their way through financial institutions as they meet the requirements of the Bank Secrecy Act (BSA).
2025-10-31T18:52:00Z By Oscar Gonzalez
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
2025-10-30T19:59:00Z By Oscar Gonzalez
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
Site powered by Webvision Cloud